Top Markets
Coin of the day
Arvee Laboratories (India) Ltd. Arvee Laboratories (India) Ltd.

Arvee Laboratories (India) Ltd.

ARVEE
Rank in Stocks #29514
Arvee Laboratories (India) Ltd., established in 2012 and headquartered in... Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. Additionally, Arvee Laboratories manufactures intermediates critical for contrast media, supplying compounds like 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. The firm also provides drug intermediates, specifically 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-amino pyridine, and 2-chloro-5-nitrobenzoic acid. Beyond its domestic sales, Arvee Laboratories actively exports its chemical products.
Share Price
$1.89
Market Cap
$20.83M
Change (1 day)
0.44%
Change (1 year)
2.38%
Country
IN
Trade Arvee Laboratories (India) Ltd. (ARVEE)
Earnings for Arvee Laboratories (India) Ltd. (ARVEE)
Earnings in 2026 TTM: 0
According to Arvee Laboratories (India) Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Arvee Laboratories (India) Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$9.38B -
GB
- -
FR
$3.49B -
US
$2.63B -
US
$-82.10M -
US